ivabradine has been researched along with Metabolic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poteshkina, NG; Troshina, AA | 1 |
| Ferrari, R; Ford, I; Fox, K; Steg, PG; Tendera, M | 1 |
1 trial(s) available for ivabradine and Metabolic Syndrome
| Article | Year |
|---|---|
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population.
Topics: Aged; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Ivabradine; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left | 2008 |
1 other study(ies) available for ivabradine and Metabolic Syndrome
| Article | Year |
|---|---|
[Coronary Heart Disease at the Patient With Metabolic Syndrome: Strategy of Antianginal Therapy].
Topics: Benzazepines; Cardiovascular Agents; Coronary Disease; Heart Rate; Humans; Ivabradine; Metabolic Syndrome | 2016 |